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TO THE EDITOR
Semaphorins are secreted and transmembrane proteins initially described as guidance signalling molecules during the embryonic development of the nervous system (Bagnard et al., 1998) . In addition, their involvement in processes controlling cardiac and skeletal development (Behar et al., 1996) , cell migration (Delaire et al., 2001) , induction of apoptosis (Tomizawa et al., 2001) , immunomodulation (Bismuth and Boumsell, 2002) , and tumor growth and metastasis (Roche et al., 1996; Christensen et al., 1998 ) is now well documented. Sema 3F is a member of the class III semaphorin family, originally isolated as a tumor suppressor of small-cell lung carcinoma (Roche et al., 1996; Sekido et al., 1996; Xiang et al., 1996) , and which receptors have been identified among the neuropilin (NRP) family (Chen et al., 1997; Kolodkin et al., 1997 ). An antimetastatic function for Sema 3F has been recently suggested in melanoma. Thus, the implantation of metastatic melanoma cells transfected with Sema 3F into nude mice resulted in a tumor that did not metastasize (Bielenberg et al., 2004) . Here we further report that Sema 3F can represent a powerful inhibitor of melanoma cell proliferation.
Because the expression of a neuropilin receptor is a pre-requisite for the generation of a Sema 3F-dependent signal, we first examined whether NRP1 and NRP2 mRNA were present in cells isolated from the melanoma cutaneous metastases of six patients. Both mRNAs were detected in the melanoma cells originating from each patient, although with varying degree of expression (Figure 1, upper and middle panel) . In addition, Sema 3F transcript was also detected in all tested samples (Figure 1, lower panel) . Therefore melanoma cells might be potential targets for Sema 3F, as they present the ability to express the low-or highaffinity receptor for this semaphorin.
The functional effects of Sema 3F on melanoma cells were explored using the human melanoma cell lines MM170 and A375. The hypothesis of Sema 3F binding to melanoma cells was investigated by semaphorin binding assays. Figure 2a clearly demonstrated an efficient interaction of Sema 3F with MM170 and A375 cell lines. The semaphorin might influence the functional behavior of these cells. We further investigated the molecular basis of Sema 3F interaction on MM170 and A375 melanoma cell lines. Because NRP1 and NRP2 mRNA synthesis was detected in both cell lines (data not shown), the cell surface expression of each receptor was analyzed by flow cytometry (Figure 2b ). The immunofluorescence labeling revealed a low expression level of NRP1 on A375 cells, whereas a higher protein amount was detected on MM170 cells (Figure 2b , left panel). In contrast, although NRP2 staining was found positive on both cell lines, a stronger level of expression was constantly observed on A375 cells when compared to MM170 (Figure 2b , middle panel). Additional protein expression analysis also led to the detection of membrane-associated Sema 3F on both cell lines (Figure 2b , right panel). Importantly, Sema 3F was also found in MM170 and A375 culture medium by performing anti-Sema 3F immunoblotting, confirming the ability of the cells to secrete properly the semaphorin (data not shown). Altogether, these data strongly suggested that, following secretion, Sema 3F might regulate MM170 and A375 cellular functions through its binding to NRP receptors.
It has been demonstrated that overexpression of Sema 3F in a mouse fibrosarcoma cell line, or in ovarian cancer cells, inhibited in vitro and in vivo cell growth but did not affect the growth of lung carcinoma cells (Tomizawa et al., 2001; Xiang et al., 2002) . Similarly, a consequent downregulation of breast cancer cell proliferation has been observed in the presence of Sema 3F (Nasarre et al., 2003) . We therefore investigated the influence of Sema 3F on the proliferative response of MM170 and A375 cell lines. The results from a representative dose-response experiment are shown in Figure 2c , and demonstrated a dose-dependent inhibitory effect of Sema 3F on MM170 and A375 cell proliferation. Importantly, the observed inhibition of proliferation did not derived from Sema 3F-induced apoptosis or cell cycle arrest (data not shown). We further confirmed the specificity of Sema 3F-mediated downregulation of cell growth by performing similar experiments on cells transiently expressing the semaphorin. A 33% Reverse transcription-PCR was performed on mRNA isolated from melanoma tumor cells of six patients (1-6). Positive ( þ ) and negative (À) controls were realized simultaneously for each amplified product using cDNA from the indicated cells as template. Dev: human pluripotent neural precursor cell line.
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inhibition of proliferation was measured on Sema 3F-expressing MM170 cells (Figure 2d ). Similarly, A375 cells exhibited a 31% reduction of cell growth and division when secreting soluble Sema 3F. Thus, Sema 3F displays a potent antiproliferative effect on both MM170 and A375 melanoma cell lines.
In this study, we demonstrated that the addition of exogenous soluble semaphorin Sema 3F, or overexpression of the endogenous molecule, efficiently affects the mechanisms regulating MM170 and A375 melanoma cell line proliferation. These results are contradictory with the one reported by Bielenberg et al. (2004) , who demonstrated that the expression of Sema 3F by melanoma tumor cells diminished their capacity to adhere and migrate but did not affect their proliferation. However, since the amount of semaphorin secreted by the transfected cells was not quantified in this study, the observed discrepancy might be attributed to the secretion of suboptimal concentrations of semaphorin (below 10 nM, according to our dose-response experiment, see Figure 2c ), for which a Sema 3F-dependent inhibition of cell proliferation will be hardly detectable. Importantly, we established that the cells isolated from the cutaneous metastases of patients with melanoma possess the transcription machinery required for a Sema 3F-induced inhibition of cell growth and division, as assessed by the synthesis of Sema 3F, NRP1, and NRP2 mRNA. Although the expression and functions of these proteins have to be confirmed on melanoma cells obtained from patients, our data strongly suggested that Sema 3F might represent a potent inhibitor of melanoma cell proliferation and could be used for therapeutic goal.
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The authors state no conflict of interest. TO THE EDITOR While skin color is the most notable difference among ethnic skins, many other differences exist in the structure and function of ethnic skins. Unfortunately, the current knowledge of physiological and pathological properties of the skin is based mainly on Caucasian skin studies (reviewed in Taylor, 2002) . Elucidating differences among ethnic skins is not only of great biological importance, but also of great interest in skin care improvement. Keratinocytes play an important role in skin physiology, affecting skin barrier function, immune responses and wound-healing processes (Williams and Kupper, 1996) . Earlier studies documented the role of the keratinocyte receptor PAR-2 in the regulation of skin pigmentation (Seiberg et al., 2000a, b; Paine et al., 2001) , and the differential expression of the PAR-2 pathway in keratinocytes of different ethnic origins (Babiarz-Magee et al., 2004) . In order to identify other differences in keratinocytes' expression profiles, we performed DNA chip analysis of keratinocytes obtained from different skin types (four individuals of either lightly (LK) or darkly (DK) pigmented skins) (Cascade Biologics, Portland, OR). When evaluating expression levels of cathepsins (chip results, Table S1 ), only cathepsin L2 (CTSL2) was found to be differentially expressed in relation to pigmentary skin backgrounds, and was about 7.5-folds higher in keratinocytes from lightly pigmented, relative to darkly pigmented skins (Table S1 ). CTSL2 is a lysosomal cysteine protease (Adachi et al., 1998; Santamaria et al., 1998; Bromme et al., 1999) . It is expressed in primary keratinocytes, melanocytes, and HaCaT keratinocytes (Figure 1a ), but not in primary fibroblasts (Figure 1b) . The differential expression of CTSL2 mRNA in keratinocytes (but not of other cathepsins and of cystatins, the natural inhibitors of cathepsins) was confirmed by reverse transcriptase (RT)-PCR ( Figure 1c ; Table S2 in Supplementary material for primers). Interestingly, melanocytes from different ethnic origins expressed the same levels of CTSL2 mRNA (Figure 1d) .
Western blot analysis of keratinocytes using polyclonal antibodies specific to CTSL2 ( Figure S1 ) showed that keratinocytes derived from lightly pigmented skins (LK) have about 3.5-fold increase in CTSL2 protein levels (normalized by b-actin) relative to those of darkly pigmented skins (DK) (Figure 2a ). In addition, CTSL2 protein levels in human skins with different levels of pigment deposition (as shown by Fontana-Mason staining, Figure 2b and c) were analyzed by immunohistochemistry staining. In agreement with the CTSL2 mRNA levels in ethnic skins, CTSL2 protein levels were found to be higher in lighter skins, and strongly reduced in darker skins (Figure 2d and e) .
To date, there are no specific inhibitors to CTSL2; therefore, we could not directly measure CTSL2 activity in keratinocyte's derived from skins of different colors. The total enzymatic activity of cathepsins was measured using substrate Z-Phe-Arg-AMC (Bachem, Torrance, CA). Substrate hydrolysis catalyzed by cathepsins was monitored by fluorescent emission (excitation at 360 nm and emission at 465 nm). Cell lysate of keratinocytes from lightly pigmented skins showed 1.570.16-fold higher cathepsin activity than keratinocytes derived from darker skins (data were pooled from three
